English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 59676/92934 (64%)
造访人次 : 825430      在线人数 : 29
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻

    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/121364

    题名: A Study on Sample Size Determination for Evaluating Within-Device Precision, Heritability, and Bioequivalence Based on Modified Large-Sample Method
    其它题名: 修正大樣本法於精密度檢測、遺傳率檢定、生體相等性檢定樣本數決定之研究
    作者: 姜杰
    关键词: Within-device precision;Heritability;Individual bioequivalence;In-vitro population bioequivalence;Modified large-sample method;Power;Sample size
    日期: 2015-01
    上传时间: 2021-09-24 12:20:15 (UTC+8)
    摘要: Statistical criteria for evaluation of precision or variation often involve functions of the second moments of the normal distribution. Under the two-stage nested random-effects model, heritability is defined as the ratio of genetic variance to the total variance. Under replicated crossover designs, the criteria for individual bioequivalence (IBE) proposed by the guidance of the US Food and Drug Administration (FDA) contain the squared mean difference, variance of treatment-by-subject interaction, and the difference in within-subject variances between the generic and innovative products. On the other hand, the criterion for evaluation of the within precision for in-vitro diagnostic devices (IVD) is the sum of the variance components due to day, run, and replicates. The criterion for the in-vitro population bioequivalence (PBE) proposed by the draft guidance of the US FDA consists of the squared mean difference, the sum of the differences in variance components due to batch, sample, and life-stage. These criteria can be reformulated as linear combinations of variance components under the logarithmic transformation. The one-sided confidence limits for the linearized criteria derived by the modified large sample (MLS) method have been proposed as the test statistics for the inference in different applications. However, due to complexity of the power function, the literature for the sample size determination for the inference based on the second moments is scarce. We proved that the distribution of the one-sided confidence bound of the linearized criterion is asymptotically normal. Hence the asymptotic power can be derived for sample size determination with different applications to within-device precision, heritability, IBE and in-vitro PBE. Simulation studies were conducted to investigate the impact of magnitudes of means differences and variance components on sample sizes. In addition, empirical powers obtained from simulation studies are compared with the asymptotic powers to examine whether the sample sizes determined by our proposed methods can provide sufficient power. The proposed methods are illustrated with real data for practical applications. Discussion, final remarks and future research are also presented.
    显示于类别:[數學學系暨研究所] 專書


    档案 大小格式浏览次数



    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - 回馈